Author:
Herpers Robert,van Rossum André P.,van Beem Rachel T.,Michel W. Margot,Strijbis Viola J.F.,Strengers Paul F.W.,Castel Ad,Brinkman Herm Jan M.
Abstract
AbstractProthrombin complex concentrate (PCC) is used to reverse vitamin K antagonist (VKA)-induced anticoagulation. Prothrombin time-derived international normalized ratio (INR) measurements are widely used in determining the required PCC dose, but this approach requires reappraisal. The aim of the present study was to determine the added value of the thrombin generation assay (TGA) compared with the INR in guidance of VKA reversal by PCC.In an open, observational study, INR and TGA measurements were carried out on plasma samples from phenprocoumon-treated patients receiving VKA reversal. Following both analytical methods, PCC dosing correlates were calculated and compared retrospectively. Alternatively, in vitro PCC spiking experiments were performed.As expected, an exponential relationship between PCC dose and INR was found. For the TGA parameters peak thrombin and endogenous thrombin potential (ETP), however, this relationship was found to be linear throughout the full therapeutic range. Additional computational analysis showed a positive correlation (rOur results support the current debate questioning the rationale for the use of the INR in the management of anticoagulation by VKA. Compared with INR, TGA-based calculations may enable a more accurate PCC dosing regimen for patients requiring VKA reversal.
Subject
Biochemistry, medical,Clinical Biochemistry,General Medicine
Reference52 articles.
1. The thrombogram in rare inherited coagulation disorders : its relation to clinical bleeding;Dieri,2002
2. The thrombogram in rare inherited coagulation disorders : its relation to clinical bleeding;Dieri,2002
3. Prothrombin complex concentrate in patients requiring immediate reversal of oral anticoagulation;Riess;Thromb Res,2007
4. British Committee for Standards in Haematology Guideline on the management of bleeding in patients on antithrombotic agents;Makris,2012
5. Bleeding risk in warfarinized patients with a therapeutic international normalized ratio : the effect of low factor IX levels;Dargaud;J Thromb Haemost,2013
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献